Answer
Mogamulizumab has a minor influence on the ability to drive or use machines, and fatigue may occur after administration.
Sources for this answer
- Poteligeo 4 mg/mL, Concentrate for Solution for InfusionKyowa Kirin Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 8Document updated
Sources checked